Yahoo! Finance: SGYPU NewsCopyright (c) 2013 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=sgypuLatest Financial News for Synergy Pharmaceuticals, Inc.en-USTue, 16 Apr 2013 17:26:47 GMThttp://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gifYahoo! Finance: SGYPU Newshttp://finance.yahoo.com/q/h?s=sgypu14445Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stockhttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1257bn3fb/*http://www.noodls.com/view/A0097F8EBC2DE482554B1851A81598F068695C8B[at noodls] - NEW YORK, April 16, 2013 -- Synergy Pharmaceuticals Inc.(Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten public offering ...yahoo_finance/3673382439Tue, 16 Apr 2013 17:26:47 GMTSynergy Pharmaceuticals Inc. Announces Pricing of Public Offering of Common Stockhttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125bpupg1/*http://www.noodls.com/view/1C88D7142130D66947DA7D0A2AF5CC14D1BBABAB[at noodls] - NEW YORK, April 10, 2013 -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced the pricing of an underwritten public ...yahoo_finance/2702418667Thu, 11 Apr 2013 01:40:39 GMTSynergy Pharmaceuticals Inc. Announces Public Offering of Common Stockhttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1252n36e2/*http://www.noodls.com/view/8AB1AD5760341F8268331659FC214EAB9EB5C7BE[at noodls] - NEW YORK, April 9, 2013 -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it is offering to sell an aggregate ...yahoo_finance/331757211Tue, 09 Apr 2013 21:32:00 GMTSynergy Pharmaceuticals Reports 2012 Fourth Quarter and Full-Year Financial Resultshttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125vfh6l1/*http://www.noodls.com/view/131EDA3766F094D9FD0582449F16FF2F818D85D5[at noodls] - NEW YORK, March 18, 2013 -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update ...yahoo_finance/160919373Mon, 18 Mar 2013 21:38:52 GMTSynergy Pharmaceuticals to Present Study Results From Plecanatide Phase IIb/III Trial in Late-Breaking Clinical Abstract at Digestive Disease Week 2013http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125c5c5lb/*http://www.noodls.com/view/D0CBBE425527EBCB2F2AA5C0DAD20218D5E9EDA1[at noodls] - NEW YORK, March 15, 2013 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that study results from the Phase IIb/III ...yahoo_finance/4174202896Sat, 16 Mar 2013 12:14:20 GMTSynergy Pharmaceuticals to Present at Two Upcoming Investor Conferenceshttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125t6ouk9/*http://www.noodls.com/view/6A2B1D5C909332F1F87C296A65C72B1288C6CE9E[at noodls] - NEW YORK, Feb. 22, 2013 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that President and CEO Gary S. Jacob, ...yahoo_finance/3393447737Fri, 22 Feb 2013 11:13:22 GMTSynergy Pharmaceuticals to Begin Trading on The NASDAQ Global Markethttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125eeq091/*http://www.noodls.com/view/75C48430366C5C8F93A9E0DDA1B227EEE72CB30B[at noodls] - NEW YORK, Feb. 11, 2013 -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its common stock has been approved ...yahoo_finance/1162698758Mon, 11 Feb 2013 11:16:49 GMTSynergy Pharmaceuticals Initiates Multiple Ascending Dose Phase Ib Trial in Healthy Volunteers of SP-333, a Second Generation Guanylate Cyclase C Agonist for the Treatment of Ulcerative Colitishttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1251leg9i/*http://www.noodls.com/view/AFF20C2407E63057ACDF8DAD76FD04E8421985C8[at noodls] - SP-333 Advances to Multiple-Dosing Safety Study NEW YORK, Jan. 28, 2013 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders, announced today ...yahoo_finance/1813557706Mon, 28 Jan 2013 11:07:35 GMTSynergy Pharmaceuticals Announces Approval of Merger With Callisto Pharmaceuticals and Other Actions at Annual Meeting of Stockholdershttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125ld0n5c/*http://www.noodls.com/view/91D653929EE3BF913752894AB4E286BD0450DCBD[at noodls] - NEW YORK, Jan. 15, 2013 -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP) ("Synergy") today announced that it convened its annual meeting of stockholders yesterday and it has received the necessary ...yahoo_finance/308060916Tue, 15 Jan 2013 11:20:16 GMTSynergy Announces Adjournment of Annual Meetinghttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125u1d9pg/*http://www.noodls.com/view/71B35FE51171B1C9B227F5D107792D04495AD879[at noodls] - NEW YORK, Jan. 3, 2013 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) today announced that it convened its annual meeting of stockholders on Thursday, January 3, 2013 and adjourned the meeting until Monday, ...yahoo_finance/4101330727Thu, 03 Jan 2013 22:15:08 GMTSynergy Announces Positive Results From Plecanatide Phase IIb/III Trial in Patients With Chronic Idiopathic Constipationhttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12582046i/*http://www.noodls.com/view/93AB682683A0EC968EAAF8E6E375BE03FEC30F52[at noodls] - Topline Data Show That Plecanatide Met Primary and Key Secondary Endpoints NEW YORK, Jan. 2, 2013 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) today announced that plecanatide, its investigational oral ...yahoo_finance/376999750Thu, 03 Jan 2013 12:23:56 GMTSynergy Pharmaceuticals Begins Phase IIb Trial of Plecanatide in Irritable Bowel Syndrome With Constipation (IBS-C)http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1253l0huc/*http://www.noodls.com/view/134140E34C2B1E81FEC1AE04BB409521F0C18B02[at noodls] - NEW YORK, Dec. 27, 2012 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that dosing has commenced in a Phase ...yahoo_finance/2493265641Thu, 27 Dec 2012 11:26:27 GMTSynergy Pharmaceuticals Presents Poster on Novel Mechanism of Action of SP-333, an Agonist of Guanylate Cyclase-C for Treatment of Ulcerative Colitishttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1250rkgql/*http://www.noodls.com/view/8B1DE2AE7B3D49B58C6D3E9B70D833C6A15D118E[at noodls] - Scientific Poster Presentation at 2012 Advances in IBD Conference NEW YORK, Dec. 14, 2012 -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and ...yahoo_finance/2871412352Fri, 14 Dec 2012 14:13:13 GMTSynergy Pharmaceuticals to Present at Piper Jaffray Healthcare Conferencehttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125s8it9f/*http://www.noodls.com/view/F92049F09701D821F1F07986FBB967514A7E05CA[at noodls] - NEW YORK, Nov. 21, 2012 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its President and CEO, Gary S. Jacob, ...yahoo_finance/2140720479Wed, 21 Nov 2012 14:28:16 GMTSynergy Pharmaceuticals Reports Third Quarter 2012 Financial Resultshttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125be16tj/*http://www.noodls.com/view/EEE2780909385BCBA793773F25A97DAC921777F0[at noodls] - Synergy Advances Clinical Programs NEW YORK, Nov. 13, 2012 -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its ...yahoo_finance/1439802512Tue, 13 Nov 2012 21:37:41 GMTSynergy Pharmaceuticals Announces Extension for Filing of Third Quarter Form 10-Q Due to Hurricane Sandyhttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1250ol1id/*http://www.noodls.com/view/C68077149F9AE5FE439FE8FB9A721DC7B94DA0BB[at noodls] - NEW YORK, Nov. 9, 2012 -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that, in accordance with applicable rules ...yahoo_finance/2138035323Fri, 09 Nov 2012 22:15:02 GMT